Neurim Pharmaceuticals licenses Circadin®, a drug approved for the treatment of primary insomnia, to Lundbeck


  • Text size: A A A
  • Circadin
  • Recent news

    • Slenyto (PedPRM) is now available in Denmark!
    • Slenyto (PedPRM) is now also available in Iceland!
    • Slenyto (PedPRM) is now available in Switzerland!
  • Partners

    Partners